ACHIEVE LIFE SCIENCES INC (ACHV) Fundamental Analysis & Valuation
NASDAQ:ACHV • US0044685008
Current stock price
4.39 USD
+0.24 (+5.78%)
At close:
4.45 USD
+0.06 (+1.37%)
After Hours:
This ACHV fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ACHV Profitability Analysis
1.1 Basic Checks
- ACHV had negative earnings in the past year.
- ACHV had a negative operating cash flow in the past year.
- In the past 5 years ACHV always reported negative net income.
- In the past 5 years ACHV always reported negative operating cash flow.
1.2 Ratios
- Looking at the Return On Assets, with a value of -130.77%, ACHV is doing worse than 81.55% of the companies in the same industry.
- ACHV has a worse Return On Equity (-253.96%) than 73.40% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -130.77% | ||
| ROE | -253.96% | ||
| ROIC | N/A |
ROA(3y)-129.26%
ROA(5y)-119.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin and Operating Margin and Gross Margin are not available for ACHV so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. ACHV Health Analysis
2.1 Basic Checks
- Compared to 1 year ago, ACHV has more shares outstanding
- ACHV has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, ACHV has a worse debt to assets ratio.
2.2 Solvency
- Based on the Altman-Z score of -5.63, we must say that ACHV is in the distress zone and has some risk of bankruptcy.
- ACHV has a Altman-Z score of -5.63. This is in the lower half of the industry: ACHV underperforms 65.83% of its industry peers.
- A Debt/Equity ratio of 0.52 indicates that ACHV is somewhat dependend on debt financing.
- With a Debt to Equity ratio value of 0.52, ACHV is not doing good in the industry: 72.62% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.63 |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
- ACHV has a Current Ratio of 4.39. This indicates that ACHV is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 4.39, ACHV is in line with its industry, outperforming 50.49% of the companies in the same industry.
- A Quick Ratio of 4.39 indicates that ACHV has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 4.39, ACHV is in line with its industry, outperforming 52.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.39 | ||
| Quick Ratio | 4.39 |
3. ACHV Growth Analysis
3.1 Past
- The earnings per share for ACHV have decreased by -5.69% in the last year.
EPS 1Y (TTM)-5.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
3.2 Future
- Based on estimates for the next years, ACHV will show a very strong growth in Earnings Per Share. The EPS will grow by 33.93% on average per year.
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-7.49%
EPS Next 2Y11.08%
EPS Next 3Y33.45%
EPS Next 5Y33.93%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. ACHV Valuation Analysis
4.1 Price/Earnings Ratio
- ACHV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year ACHV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- ACHV's earnings are expected to grow with 33.45% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y11.08%
EPS Next 3Y33.45%
5. ACHV Dividend Analysis
5.1 Amount
- No dividends for ACHV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
ACHV Fundamentals: All Metrics, Ratios and Statistics
4.39
+0.24 (+5.78%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Industry Strength55.9
Industry Growth13.04
Earnings (Last)03-24 2026-03-24/bmo
Earnings (Next)05-07 2026-05-07
Inst Owners46.11%
Inst Owner Change0.07%
Ins Owners4.61%
Ins Owner Change0%
Market Cap233.72M
Revenue(TTM)N/A
Net Income(TTM)-54.65M
Analysts81.54
Price Target15.88 (261.73%)
Short Float %13.54%
Short Ratio6.52
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.94%
Min EPS beat(2)-6.75%
Max EPS beat(2)-1.13%
EPS beat(4)2
Avg EPS beat(4)-1.85%
Min EPS beat(4)-6.75%
Max EPS beat(4)0.34%
EPS beat(8)2
Avg EPS beat(8)-7.87%
EPS beat(12)5
Avg EPS beat(12)-0.3%
EPS beat(16)7
Avg EPS beat(16)-2.66%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)1.28%
PT rev (3m)1.28%
EPS NQ rev (1m)-0.85%
EPS NQ rev (3m)-0.85%
EPS NY rev (1m)-21.83%
EPS NY rev (3m)-22.74%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-100%
Revenue NY rev (3m)-100%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | N/A | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 10.86 | ||
| P/tB | 11.84 | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.3
EYN/A
EPS(NY)-1.4
Fwd EYN/A
FCF(TTM)-0.93
FCFYN/A
OCF(TTM)-0.93
OCFYN/A
SpS0
BVpS0.4
TBVpS0.37
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -130.77% | ||
| ROE | -253.96% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | N/A | ||
| FCFM | N/A |
ROA(3y)-129.26%
ROA(5y)-119.77%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.52 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.32% | ||
| Cap/Sales | N/A | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 4.39 | ||
| Quick Ratio | 4.39 | ||
| Altman-Z | -5.63 |
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%22.22%
EPS Next Y-7.49%
EPS Next 2Y11.08%
EPS Next 3Y33.45%
EPS Next 5Y33.93%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-40.47%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-66.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-66.16%
OCF growth 3YN/A
OCF growth 5YN/A
ACHIEVE LIFE SCIENCES INC / ACHV Fundamental Analysis FAQ
What is the fundamental rating for ACHV stock?
ChartMill assigns a fundamental rating of 1 / 10 to ACHV.
What is the valuation status of ACHIEVE LIFE SCIENCES INC (ACHV) stock?
ChartMill assigns a valuation rating of 1 / 10 to ACHIEVE LIFE SCIENCES INC (ACHV). This can be considered as Overvalued.
How profitable is ACHIEVE LIFE SCIENCES INC (ACHV) stock?
ACHIEVE LIFE SCIENCES INC (ACHV) has a profitability rating of 0 / 10.
Can you provide the financial health for ACHV stock?
The financial health rating of ACHIEVE LIFE SCIENCES INC (ACHV) is 3 / 10.